|
US3740412A
(en)
|
1970-04-08 |
1973-06-19 |
Synvar Ass |
Imidazoline-3-oxide-1-oxyl derivatives
|
|
US3997223A
(en)
|
1975-04-30 |
1976-12-14 |
Dynascan Corporation |
Apparatus and method for rejuvenating cathode ray tubes
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4267333A
(en)
|
1979-09-26 |
1981-05-12 |
Union Carbide Agricultural Products Company, Inc. |
Preparation of 2-trifluoromethyl cinchoninic acids
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4435419A
(en)
|
1981-07-01 |
1984-03-06 |
American Cyanamid Company |
Method of treating depression using azabicyclohexanes
|
|
US4431661A
(en)
|
1981-08-20 |
1984-02-14 |
American Cyanamid Company |
5-Aryl-3-azabicyclo[3.2.0]heptan-6-one acetals, and analgesic use therefor
|
|
AU534404B2
(en)
|
1981-09-01 |
1984-01-26 |
American Cyanamid Company |
Cyclopropane derivatives
|
|
US4490055A
(en)
|
1982-06-30 |
1984-12-25 |
International Business Machines Corporation |
Automatically adjustable delay function for timed typamatic
|
|
US4544665A
(en)
|
1983-11-21 |
1985-10-01 |
American Cyanamid Company |
1-Aryl-3-azabicyclo[3.2.0]heptanes
|
|
GB2200628A
(en)
|
1987-02-06 |
1988-08-10 |
Shell Int Research |
Diphenyl ether herbicides
|
|
US5089633A
(en)
|
1987-04-28 |
1992-02-18 |
Georgia Tech Research Corporation |
Substituted isocoumarins
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
JPH032797A
(ja)
|
1989-05-30 |
1991-01-09 |
Meidensha Corp |
音声合成装置の抑揚制御方式
|
|
WO1994000555A2
(en)
|
1992-06-25 |
1994-01-06 |
Cetus Oncology Corporation |
Compositions for the inhibition of protein hormone formation and uses thereof
|
|
US5120752A
(en)
|
1989-12-28 |
1992-06-09 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5037853A
(en)
|
1989-12-28 |
1991-08-06 |
Abbott Laboratories |
Cyclopropyl derivative lipoxygenase inhibitors
|
|
US5114953A
(en)
|
1990-11-21 |
1992-05-19 |
University Of Florida |
Treatment for tissue ulceration
|
|
GB9102635D0
(en)
|
1991-02-07 |
1991-03-27 |
British Bio Technology |
Compounds
|
|
US5256657A
(en)
|
1991-08-19 |
1993-10-26 |
Sterling Winthrop, Inc. |
Succinamide derivative matrix-metalloprotease inhibitors
|
|
JP3333510B2
(ja)
|
1991-10-02 |
2002-10-15 |
スミスクライン・ビーチャム・コーポレイション |
抗アレルギー、抗炎症および腫瘍壊死因子抑制活性を有するシクロペンタンおよびシクロペンテン誘導体
|
|
JPH05262698A
(ja)
|
1992-03-24 |
1993-10-12 |
Dainippon Ink & Chem Inc |
光学活性トリフルオロメチルシクロプロパン誘導体、その合成中間体、それを含む液晶組成物及び液晶表示素子
|
|
AU3899193A
(en)
|
1992-04-07 |
1993-11-08 |
British Bio-Technology Limited |
Hydroxamic acid based collagenase and cytokine inhibitors
|
|
US5674901A
(en)
|
1995-06-01 |
1997-10-07 |
Wisconsin Alumni Research Foundation |
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
|
|
US5318964A
(en)
|
1992-06-11 |
1994-06-07 |
Hoffmann-La Roche Inc. |
Hydroxamic derivatives and pharmaceutical compositions
|
|
GB9215665D0
(en)
|
1992-07-23 |
1992-09-09 |
British Bio Technology |
Compounds
|
|
GB9223904D0
(en)
|
1992-11-13 |
1993-01-06 |
British Bio Technology |
Inhibition of cytokine production
|
|
US5552419A
(en)
|
1993-01-06 |
1996-09-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5646167A
(en)
|
1993-01-06 |
1997-07-08 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamix acids
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5506242A
(en)
|
1993-01-06 |
1996-04-09 |
Ciba-Geigy Corporation |
Arylsufonamido-substituted hydroxamic acids
|
|
CN1105799A
(zh)
|
1993-03-18 |
1995-07-26 |
大制药株式会社 |
作为基质金属蛋白酶抑制剂的喹诺酮衍生物
|
|
GB9307956D0
(en)
|
1993-04-17 |
1993-06-02 |
Walls Alan J |
Hydroxamic acid derivatives
|
|
JPH072797A
(ja)
|
1993-04-19 |
1995-01-06 |
Sankyo Co Ltd |
コラゲナーゼ阻害剤
|
|
GB9311282D0
(en)
*
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
JPH09503201A
(ja)
|
1993-08-23 |
1997-03-31 |
イミュネックス・コーポレーション |
Ｔｎｆ−アルファ分泌の阻害剤
|
|
US5594106A
(en)
|
1993-08-23 |
1997-01-14 |
Immunex Corporation |
Inhibitors of TNF-α secretion
|
|
GB9320660D0
(en)
|
1993-10-07 |
1993-11-24 |
British Bio Technology |
Inhibition of cytokine production
|
|
PT822186E
(pt)
|
1994-01-20 |
2000-08-31 |
British Biotech Pharm |
L-tert-leucina-2-piridilamida
|
|
GB9401129D0
(en)
|
1994-01-21 |
1994-03-16 |
British Bio Technology |
Hydroxamic acid derivatives as metalloproteinase inhibitors
|
|
EP0905126B1
(en)
|
1994-01-22 |
2002-12-04 |
British Biotech Pharmaceuticals Limited |
Metalloproteinase inhibitors
|
|
US5514716A
(en)
|
1994-02-25 |
1996-05-07 |
Sterling Winthrop, Inc. |
Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
|
|
WO1995024501A1
(en)
|
1994-03-07 |
1995-09-14 |
Cetus Oncology Corporation |
Compositions for the inhibition of tnf formation and uses thereof
|
|
GB9501737D0
(en)
|
1994-04-25 |
1995-03-22 |
Hoffmann La Roche |
Hydroxamic acid derivatives
|
|
WO1995029892A1
(en)
|
1994-04-28 |
1995-11-09 |
The Du Pont Merck Pharmaceutical Company |
Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
|
|
US5817822A
(en)
|
1994-06-24 |
1998-10-06 |
Novartis Corporation |
Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
|
|
US5840698A
(en)
|
1994-10-27 |
1998-11-24 |
Affymax Technologies N.V. |
Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
|
|
JP2902318B2
(ja)
|
1994-12-28 |
1999-06-07 |
呉羽化学工業株式会社 |
エスクレチン誘導体、その製造方法及びマトリックスメタロプロテアーゼ阻害剤
|
|
US5703092A
(en)
|
1995-04-18 |
1997-12-30 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic acid compounds as metalloprotease and TNF inhibitors
|
|
US5691381A
(en)
|
1995-04-18 |
1997-11-25 |
The Dupont Merck Pharmaceutical Company |
Hydroxamic and carbocyclic acids as metalloprotease inhibitors
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
GB2303130A
(en)
|
1995-07-10 |
1997-02-12 |
Secr Defence |
Cyclic oligomers of substituted cyclic ethers
|
|
GB9514867D0
(en)
|
1995-07-20 |
1995-09-20 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
EP0848957A1
(en)
|
1995-09-08 |
1998-06-24 |
Kanebo Ltd. |
Fas LIGAND SOLUBILIZATION INHIBITOR
|
|
WO1997012902A1
(en)
|
1995-10-05 |
1997-04-10 |
Darwin Discovery Limited |
Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
|
|
US5665777A
(en)
|
1995-11-14 |
1997-09-09 |
Abbott Laboratories |
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
|
|
CA2237524A1
(en)
|
1995-11-14 |
1997-05-22 |
Du Pont Pharmaceuticals Company |
Novel macrocyclic compounds as metalloprotease inhibitors
|
|
ATE205184T1
(de)
|
1995-11-23 |
2001-09-15 |
British Biotech Pharm |
Metalloproteinase inhibitoren
|
|
ES2233275T3
(es)
|
1995-12-08 |
2005-06-16 |
Agouron Pharmaceuticals, Inc. |
Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
|
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
TW453995B
(en)
|
1995-12-15 |
2001-09-11 |
Novartis Ag |
Certain alpha-substituted arylsulfonamido acetohydroxamic acids
|
|
ATE225343T1
(de)
|
1995-12-20 |
2002-10-15 |
Hoffmann La Roche |
Matrix-metalloprotease inhibitoren
|
|
PT871439E
(pt)
|
1996-01-02 |
2004-08-31 |
Aventis Pharma Inc |
Compostos do acido hidroxamico substituidos (arilo heteroarilo arilmetilo ou heteroarilmetilo)
|
|
JPH09202774A
(ja)
*
|
1996-01-25 |
1997-08-05 |
Green Cross Corp:The |
２−アリールキノリン類およびその製造方法
|
|
TW448172B
(en)
|
1996-03-08 |
2001-08-01 |
Pharmacia & Upjohn Co Llc |
Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
|
|
DE69723258T2
(de)
|
1996-04-23 |
2004-01-29 |
Upjohn Co |
Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren
|
|
WO1997042168A1
(en)
|
1996-05-06 |
1997-11-13 |
Zeneca Limited |
Thio derivatives of hydroxamic acids
|
|
IT1283637B1
(it)
|
1996-05-14 |
1998-04-23 |
Italfarmaco Spa |
Composti ad attivita' antinfiammatoria ed immunosoppressiva
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
WO1998002557A2
(en)
|
1996-07-12 |
1998-01-22 |
Schering Corporation |
MAMMALIAN TNF-α CONVERTASES
|
|
US5853977A
(en)
|
1996-07-12 |
1998-12-29 |
Schering Corporation |
Mammalian TNF-α convertases
|
|
KR20000067904A
(ko)
|
1996-07-18 |
2000-11-25 |
디. 제이. 우드, 스피겔 알렌 제이 |
매트릭스 메탈로프로테아제의 포스피네이트계 억제제
|
|
JP2001505869A
(ja)
|
1996-07-22 |
2001-05-08 |
モンサント カンパニー |
チオールスルホン メタロプロテアーゼ阻害剤
|
|
KR20000068248A
(ko)
|
1996-08-23 |
2000-11-25 |
디. 제이. 우드, 스피겔 알렌 제이 |
아릴설포닐아미노 하이드록삼산 유도체
|
|
ATE226573T1
(de)
|
1996-08-28 |
2002-11-15 |
Procter & Gamble |
Heterozyklische metalloproteaseinhibitoren
|
|
BR9713182A
(pt)
|
1996-08-28 |
1999-11-03 |
Procter & Gamble |
Amidas de ácido fosfìnico como inibidores de metalo protease de matriz
|
|
DE69716934T2
(de)
|
1996-08-28 |
2003-07-31 |
The Procter & Gamble Company, Cincinnati |
1,3-diheterozyklische metalloprotease inhibitoren
|
|
KR100339296B1
(ko)
|
1996-08-28 |
2002-06-03 |
데이비드 엠 모이어 |
헤테로고리성 메탈로프로테아제 억제제
|
|
EA002113B1
(ru)
|
1996-09-04 |
2001-12-24 |
Пфайзер Инк. |
Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
|
|
JP2002514180A
(ja)
|
1996-09-04 |
2002-05-14 |
ワーナー―ランバート・コンパニー |
マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
|
|
ATE229034T1
(de)
|
1996-09-19 |
2002-12-15 |
Aventis Pharma Inc |
3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
|
|
KR20000048639A
(ko)
|
1996-09-27 |
2000-07-25 |
로렌스 티. 마이젠헬더 |
매트릭스 메탈로프로테이나제 억제제인 베타-술포닐 히드록삼산
|
|
WO1998015525A1
(en)
|
1996-10-07 |
1998-04-16 |
Sumitomo Pharmaceuticals Co., Ltd. |
Hydroxamic acids
|
|
HUP0000641A3
(en)
|
1996-10-16 |
2001-02-28 |
American Cyanamid Company Madi |
Ortho-sulfonamido aryl hydroxamic acid derivatives, their use, as matrix metalloproteinase and tace inhibitors and pharmaceutical compositions containing them
|
|
US5977408A
(en)
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
AU736134B2
(en)
|
1996-10-16 |
2001-07-26 |
Wyeth Holdings Corporation |
Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5962481A
(en)
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
JP2001503037A
(ja)
|
1996-10-16 |
2001-03-06 |
アメリカン・サイアナミド・カンパニー |
マトリクス金属プロテナイーゼおよびｔａｃｅに対する阻害薬としてのオルト―スルホンアミドヘテロアリールヒドロキサム酸の製造および使用
|
|
AU743901B2
(en)
|
1996-10-16 |
2002-02-07 |
Wyeth Holdings Corporation |
Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors
|
|
GB9621814D0
(en)
|
1996-10-19 |
1996-12-11 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US6008243A
(en)
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
MY117687A
(en)
|
1996-10-31 |
2004-07-31 |
Bayer Corp |
Substituted 4-biphenyl-4-hydroxybutric acid derivatives as matrix metalloprotease inhibitors
|
|
JPH10130217A
(ja)
|
1996-11-01 |
1998-05-19 |
Kotobuki Seiyaku Kk |
カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物
|
|
GB9624817D0
(en)
|
1996-11-28 |
1997-01-15 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
US5840974A
(en)
|
1996-12-04 |
1998-11-24 |
Britisch Biotech Pharmaceuticals, Ltd. |
Metalloproteinase inhibitors
|
|
WO1998027069A1
(en)
|
1996-12-17 |
1998-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
JP3338064B2
(ja)
|
1997-01-06 |
2002-10-28 |
ファイザー・インク |
環状スルホン誘導体
|
|
ZA9820B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
Macrocyclic inhibitors of matrix metalloproteinases and tnf x secretion
|
|
ZA9818B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
|
|
US5837696A
(en)
|
1997-01-15 |
1998-11-17 |
The Research Foundation Of State University Of New York |
Method of inhibiting cancer growth
|
|
JPH10204054A
(ja)
|
1997-01-21 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
JPH10204059A
(ja)
|
1997-01-22 |
1998-08-04 |
Ono Pharmaceut Co Ltd |
フェニルスルホンアミド誘導体
|
|
PL334846A1
(en)
|
1997-01-23 |
2000-03-27 |
Hoffmann La Roche |
Sulphamidic inhibitors of metaloproteases
|
|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
WO1998038167A1
(en)
|
1997-02-26 |
1998-09-03 |
Pfizer Inc. |
Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
|
|
PL335378A1
(en)
|
1997-02-26 |
2000-04-25 |
Glaxo Group Ltd |
Derivatives of inverse hydroxamates as metaloprotease inhibitors
|
|
YU40999A
(sh)
|
1997-02-27 |
2002-06-19 |
American Cyanamid Company |
N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze
|
|
US6172057B1
(en)
|
1997-02-27 |
2001-01-09 |
American Cyanamid Company |
N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
US6197791B1
(en)
|
1997-02-27 |
2001-03-06 |
American Cyanamid Company |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
CN1245993C
(zh)
|
1997-03-11 |
2006-03-22 |
阿特纳赞塔里斯公司 |
用于治疗肿瘤的含有鲨鱼软骨提取物和抗肿瘤剂的药物组合物
|
|
US6034136A
(en)
|
1997-03-20 |
2000-03-07 |
Novartis Ag |
Certain cyclic thio substituted acylaminoacid amide derivatives
|
|
US6251913B1
(en)
|
1997-03-28 |
2001-06-26 |
Zeneca Limited |
Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
|
|
US5985900A
(en)
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
WO1998043963A1
(en)
|
1997-04-01 |
1998-10-08 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
AT404904B
(de)
|
1997-04-03 |
1999-03-25 |
Prior Eng Ag |
Vorrichtung zur kontinuierlichen annularen chromatographie
|
|
GB9707333D0
(en)
|
1997-04-11 |
1997-05-28 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
PT877019E
(pt)
|
1997-05-09 |
2002-05-31 |
Hoechst Ag |
Acidos diaminocarboxilicos substituidos
|
|
DE19719621A1
(de)
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarbonsäuren
|
|
WO1998050348A1
(en)
|
1997-05-09 |
1998-11-12 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
US5804581A
(en)
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
GB9710490D0
(en)
|
1997-05-21 |
1997-07-16 |
British Biotech Pharm |
Metalloproteinase inhibitors
|
|
EP0887077A1
(de)
|
1997-06-27 |
1998-12-30 |
Boehringer Mannheim Gmbh |
Verwendung von Azulenderivaten als Metalloproteaseinhibitoren
|
|
WO1999002510A1
(en)
|
1997-07-10 |
1999-01-21 |
Pharmacia & Upjohn S.P.A. |
Matrix metalloproteinase inhibitors
|
|
EP1003751A1
(en)
|
1997-08-04 |
2000-05-31 |
Amgen Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
ES2176913T3
(es)
|
1997-08-08 |
2002-12-01 |
Pfizer Prod Inc |
Derivados de acidos arilsulfonilaminohidroxamicos.
|
|
ZA988967B
(en)
|
1997-10-03 |
2000-04-03 |
Du Pont Pharm Co |
Lactam metalloprotease inhibitors.
|
|
US6399612B1
(en)
|
1997-10-06 |
2002-06-04 |
Warner-Lambert Company |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
PT1021413E
(pt)
|
1997-10-06 |
2003-10-31 |
Wyeth Corp |
A preparacao e utilizacao de acidos orto-sulfonamido heterociclicos biciclicos hidroxamicos como inibidores de metaloproteinases de matriz e de tace
|
|
EP1024134A4
(en)
|
1997-10-09 |
2003-05-14 |
Ono Pharmaceutical Co |
DERIVATIVES OF AMINOBUTANIC ACID
|
|
ATE293603T1
(de)
*
|
1997-10-14 |
2005-05-15 |
Mitsubishi Pharma Corp |
Piperazin-verbindungen und ihre medizinische verwendung
|
|
EP1030851B1
(en)
|
1997-11-12 |
2005-01-12 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
GB9723905D0
(en)
|
1997-11-12 |
1998-01-07 |
Chiroscience Ltd |
Heterocyclic compounds having MMP and TNF inhibitory activity
|
|
BR9814147A
(pt)
|
1997-11-12 |
2000-10-03 |
Darwin Discovery Ltd |
"derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf"
|
|
NZ503642A
(en)
|
1997-11-13 |
2001-10-26 |
British Biotech Pharm |
N1-[2,2-Dimethyl-1S-(pyridin-2-ylcarbamoyl)-propyl]-N4-hydroxy-2R-isobutyl-3S-methoxy-succinamide
|
|
FR2771095B1
(fr)
|
1997-11-14 |
1999-12-17 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO1999031052A1
(fr)
|
1997-12-12 |
1999-06-24 |
Fuji Yakuhin Kogyo Kabushiki Kaisha |
Nouveaux inhibiteurs de metalloproteinases
|
|
EP0922702A1
(de)
|
1997-12-13 |
1999-06-16 |
Roche Diagnostics GmbH |
Neue Azulenderivate und diese enthaltende Arzneimittel
|
|
US6335329B1
(en)
|
1997-12-19 |
2002-01-01 |
Amgen Inc. |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
|
|
US6107291A
(en)
|
1997-12-19 |
2000-08-22 |
Amgen Inc. |
Azepine or larger medium ring derivatives and methods of use
|
|
WO1999032463A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
|
EP1044173A4
(en)
|
1997-12-23 |
2005-03-09 |
Spectran Corp |
LARGE SCALE MANUFACTURING PROCESS OF OPTICAL FIBER PREFORMS WITH IMPROVED CHARACTERISTICS
|
|
US6071903A
(en)
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
EP1051407A1
(en)
|
1998-01-27 |
2000-11-15 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
|
|
AU735929B2
(en)
|
1998-01-30 |
2001-07-19 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives
|
|
JP4750272B2
(ja)
|
1998-02-04 |
2011-08-17 |
ノバルティス アーゲー |
マトリックス分解メタロプロテイナーゼを阻害するスルホニルアミノ誘導体
|
|
PL342373A1
(en)
|
1998-02-06 |
2001-06-04 |
Darwin Discovery Ltd |
Derivatives of hydroxamic and carboxylic acids
|
|
WO1999042436A1
(en)
|
1998-02-19 |
1999-08-26 |
American Cyanamid Company |
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
EP0952148B1
(en)
*
|
1998-04-10 |
2004-05-12 |
Pfizer Products Inc. |
Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
|
|
AU4074799A
(en)
|
1998-05-14 |
1999-11-29 |
Du Pont Pharmaceuticals Company |
Substituted aryl hydroxamic acids as metalloproteinase inhibitors
|
|
CN1301265A
(zh)
|
1998-05-14 |
2001-06-27 |
杜邦药品公司 |
新的用作金属蛋白酶抑制剂的取代的芳基异羟肟酸
|
|
US6288063B1
(en)
|
1998-05-27 |
2001-09-11 |
Bayer Corporation |
Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
|
|
CA2333554A1
(en)
|
1998-06-17 |
1999-12-23 |
Chu-Baio Xue |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
FR2780402B1
(fr)
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE19831980A1
(de)
|
1998-07-16 |
2000-01-20 |
Hoechst Marion Roussel De Gmbh |
Sulfonylaminophosphin- und phosphonsäurederivate
|
|
CN1310716A
(zh)
|
1998-07-30 |
2001-08-29 |
沃尼尔·朗伯公司 |
作为基质金属蛋白酶抑制剂的三环磺胺化合物及其衍生物
|
|
WO2000006560A1
(en)
|
1998-07-30 |
2000-02-10 |
Warner-Lambert Company |
Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
|
|
UA59453C2
(uk)
|
1998-08-12 |
2003-09-15 |
Пфайзер Продактс Інк. |
Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
|
|
JP2002523454A
(ja)
|
1998-08-26 |
2002-07-30 |
グラクソ グループ リミテッド |
治療剤としてのホルムアミド類
|
|
WO2000012466A1
(en)
|
1998-08-26 |
2000-03-09 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
WO2000012082A1
(en)
|
1998-08-26 |
2000-03-09 |
Glaxo Group Limited |
Formamide compounds as therapeutic agents
|
|
US6479502B1
(en)
|
1998-08-29 |
2002-11-12 |
British Biotech Pharmaceuticals |
Hydroxamic acid derivatives as proteinase inhibitors
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
BR9913562A
(pt)
|
1998-09-11 |
2001-05-22 |
Ajinomoto Kk |
Derivados de benzeno, inibidor de ativação de ap-1 e nf-capa b, inibidor de produção de citoquina inflamatória, inibidor de produção de metaloprotease matricial ou inibidor de aparecimento de fator de adesão de célula inflamatório, e, agente antiinflamatório, anti-reumático, imunossupressor, inibidor de metástase cancerosa, remédio para arterioesclerose e agente antiviral
|
|
US6451792B1
(en)
|
1998-09-22 |
2002-09-17 |
Ishihara Sangyo Kaisha Ltd. |
Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
|
|
WO2000024720A1
(en)
|
1998-10-23 |
2000-05-04 |
Dow Agrosciences Llc |
3-(substituted phenyl)-5-(substituted cyclopropyl)-1,2,4-triazole compounds
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
GB9826153D0
(en)
|
1998-11-27 |
1999-01-20 |
Hoffmann La Roche |
Hydrazine derivatives
|
|
AU765729B2
(en)
|
1998-12-11 |
2003-09-25 |
F. Hoffmann-La Roche Ag |
Cyclic hydrazine derivatives as TNF-alpha inhibitors
|
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
|
WO2000037433A1
(en)
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
CA2355836A1
(en)
|
1998-12-22 |
2000-06-29 |
Ppd Development, Lp |
Genetic suppressor elements against human immunodeficiency virus
|
|
EP1150976B1
(en)
|
1998-12-31 |
2003-02-26 |
Aventis Pharmaceuticals Inc. |
3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
|
|
CA2358955A1
(en)
|
1998-12-31 |
2000-07-13 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
MXPA01006896A
(es)
|
1999-01-07 |
2002-06-04 |
Fujisawa Pharmaceutical Co |
Compuestos de tiopirano como inhibidores de metaloproteinas de matriz (mpm).
|
|
EP1141726B1
(en)
|
1999-01-14 |
2004-08-04 |
CA*TX, Inc. |
Immunoassays to detect diseases or disease susceptibility traits
|
|
FR2788525B1
(fr)
|
1999-01-19 |
2002-11-29 |
Commissariat Energie Atomique |
Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles
|
|
US6294539B1
(en)
|
1999-01-19 |
2001-09-25 |
Advanced Syntech, Llc |
Heterocyclic hydroxamic acid derivatives as MMP inhibitors
|
|
AR022422A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Inhibidores de tace acetilenicos de acido hidroxamico de heteroarilfulfonamida y amida del acido fosfinico
|
|
AR035478A1
(es)
|
1999-01-27 |
2004-06-02 |
Wyeth Corp |
Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene
|
|
AR022423A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
AR022424A1
(es)
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos ortosulfonamido acetilenico e hidroxamico biciclico heteroarilo amido de acido fosfinico como inhibidores tace, composicionfarmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
|
|
US6358980B1
(en)
|
1999-01-27 |
2002-03-19 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
AU766192B2
(en)
|
1999-01-27 |
2003-10-09 |
Wyeth Holdings Corporation |
Acetylenic sulfonamide thiol tace inhibitors
|
|
AR035311A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
AR035313A1
(es)
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
|
|
AU2320500A
(en)
|
1999-02-02 |
2000-08-25 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives having cyclic structures
|
|
HRP20010660A2
(en)
|
1999-02-08 |
2005-02-28 |
G.D. Searle & Co |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
US6177077B1
(en)
|
1999-02-24 |
2001-01-23 |
Edward L. Tobinick |
TNT inhibitors for the treatment of neurological disorders
|
|
NZ514453A
(en)
|
1999-02-26 |
2003-04-29 |
Merck & Co Inc |
Novel sulfonamide compounds and uses thereof
|
|
AU3196300A
(en)
|
1999-03-26 |
2000-10-16 |
Shionogi & Co., Ltd. |
Carbocyclic sulfonamide derivatives
|
|
WO2000058278A1
(fr)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Derives d'acides amines $g(b)
|
|
WO2000058304A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Heterocyclic sulfonamide derivatives
|
|
DE60003863T2
(de)
|
1999-03-31 |
2004-04-22 |
Pfizer Products Inc., Groton |
Dioxocyclopentylhydroxamsäure
|
|
EP1165500A1
(en)
*
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
AUPP982399A0
(en)
|
1999-04-19 |
1999-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Mmp inhibitor
|
|
AU4249700A
(en)
|
1999-04-19 |
2000-11-02 |
Sumitomo Pharmaceuticals Company, Limited |
Hydroxamic acid derivative
|
|
AU765203B2
(en)
|
1999-04-19 |
2003-09-11 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives having oxadiazole rings
|
|
GB9911071D0
(en)
|
1999-05-12 |
1999-07-14 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives
|
|
AU4614000A
(en)
|
1999-05-17 |
2000-12-05 |
Daiichi Fine Chemical Co., Ltd. |
Novel hydroxamic acid derivatives
|
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
|
GB9922825D0
(en)
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Medical use
|
|
US6632667B1
(en)
|
1999-10-28 |
2003-10-14 |
Isis Pharmaceuticals, Inc. |
Modulation of L-selectin shedding via inhibition of tumor necrosis factor-α converting enzyme (TACE)
|
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
|
ATE516497T1
(de)
|
2000-03-06 |
2011-07-15 |
Asterand Acquisition Llc |
Screening für funktionshomologien
|
|
DE60102137T2
(de)
|
2000-03-17 |
2004-10-21 |
Bristol Myers Squibb Pharma Co |
Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
|
|
IL151552A0
(en)
|
2000-03-17 |
2003-04-10 |
Bristol Myers Squibb Pharma Co |
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
|
|
EP1282614B1
(en)
|
2000-05-15 |
2003-11-12 |
Darwin Discovery Limited |
Hydroxamic acid derivatives
|
|
US6620823B2
(en)
|
2000-07-11 |
2003-09-16 |
Bristol-Myers Squibb Pharme Company |
Lactam metalloprotease inhibitors
|
|
WO2002018326A1
(en)
|
2000-08-31 |
2002-03-07 |
Wakunaga Pharmaceutical Co., Ltd. |
Novel propenohydroxamic acid derivatives
|
|
CA2447475A1
(en)
|
2001-05-25 |
2002-12-05 |
Chu-Biao Xue |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
|
SE519050C2
(sv)
|
2001-05-28 |
2003-01-07 |
Fazer Ab Oy Karl |
Påfyllnadsanordning för varor
|
|
WO2003016248A2
(en)
|
2001-08-17 |
2003-02-27 |
Bristol-Myers Squibb Company Patent Department |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
|
|
US6740649B2
(en)
|
2001-09-17 |
2004-05-25 |
Bristol-Myers Squibb Company |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
|